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The kidney is often the victim of aggressions of extra-renal origin. It`s structure and 
functions make it susceptible to pathological changes that take place within the living organism. 
The increased blood pressure inside the capillaries belonging to the glomeruli, the 
ultrafiltration function and the powerful negative charge of the local filtration glycoproteins are all 
elements that increase the sensibility of the kidney to the potentially damaging action of the 
exogenous or endogenous circulating substances. 
Depending on the pathogenetic mechanisms, immune mediated glomerulonephritis may 
be:  
1. Glomerulonephritis caused by immune complexes deposited inside the glomeruli; 
2. Glomerulonephritis caused by anti-basal membrane antibodies. 
 
1. Membranous glomerulonephritis 
Membrane glomerulonephritis are characterized by the deposition of immune complexes 
[Ig G, Ig M, C3, membrane attack complexes (C5b-C9)] in all segments of the glomerulus 
(Trautwein, 2000). 
The name of this type of lesion is borrowed from the Anglo-Saxon literature and illustrates 
the particular aspect of the basement membranes of the glomerular capillaries. However, in some 
situations it was possible to identify the antigen that forms the immune complexes retained at the 
glomerular level. Thus, membranous glomerulonephritis was observed in adenovirus infections in 
dogs, infestations with Dirofilaria immitis in dogs, infections with feline leukosis virus in cats 
(FeLV). Still, 70% of these cases remain idiopathic (Lees, 1997). 
Immune complexes, regardless of their provenance, produce glomerular lesions through a 
similar pathogenetic mechanism. Electron-microscopy studies on dogs with idiopathic 
membranous glomerulonephritis have been able to deduce the evolutionary stages of this lesion. 
In the first phase, very discrete, electron-dense immune deposits were observed on the 
epithelial surface of the glomerular basal membrane. Subsequently, there was a slight thickening 
of the basal membrane and a fusion of the podocyte processes over the immune deposits present at 
the membrane level with a diffuse and very rarely localized appearance. The podocytes appeared 
swollen and the podocyte processes also contained a granular material. 
Subsequently the thickening of the basement membranes becomes evident through the new 
synthesized membrane material, visible between the membrane deposits and the basal membrane 
itself. It appears as small spots and spicules on the epithelial surface of the glomerular basal 
membrane, giving it a comb-like aspect easily identifiable in the silver impregnation (Moreau, 
1989; Angus, 1990; Tennant, 1992; Vilafranca, 1994). 
Studies on human membranous glomerulonephritis have revealed that spicules are actually 
extensions of the basement membrane consisting mainly of α3 and α5 chains of type IV collagen 





In late evolutionary stages, membranous spicules merge with the immune membranary 
deposits and the capillary wall thickens considerably. There is also a slight proliferation of the 
mesangial cells and a development of the mesangial matrix. 
Finally, the glomerular basement membrane becomes distorted, folded, loses its 
polyanionic load and becomes highly permissive, especially for serum proteins. Thus, proteinuria 
and nephrotic syndrome can develop. 
In 15% of cases, the evolution of the disease is favorable, the lesions being mostly 
reversible, in the rest of the cases a progressive evolution towards glomerular sclerosis is observed, 
following the obliteration of the capillaries (Moreau, 1989). 
Clinically, membranous glomerulonephritis are most often accompanied by nephrotic 
syndrome (Moreau, 1989). Most membranous glomerulonephritis evolve as a generalized and 
global syndrome, being idiopathic (the composition of circulating immune complexes could not be 
identified) or being the expression of various pathological processes (infections, neoplastic 
processes, intoxication or autoimmune diseases) (Carpenter, 2002; Scott, 2001) . 
Membranous glomerulonephritis can be an expression of old age (continuous synthesis of 
membranous material), heavy metal poisoning (gold, mercury), chronic septic diseases (pyometra 
in bitches), parasitic infestations, association with chronic interstitial nephritis (in dogs), systemic 
metabolic disorders (diabetes, thyroiditis) or idiopathic (unidentified immune complexes) (Jones, 
1986). 
 
2. Mesangial glomerulonephritis (mesangio-proliferative) 
Histologically, mesangio-proliferative glomerulonephritis are dominated by cell 
proliferation, ultimately leading to a multicellular or polynuclear aspect of the Malpighi corpus 
(Oprean, 2002; Paul, 1991). 
This type of immune mediated glomerulonephritis is the one most commonly seen, being 
dominated by the cellular and matriceal changes of the glomerular mesangium, morphologically 
translated into a more or less discrete increase in the cell numbers within its structure, as a result 
of the proliferation of the mesangial and endothelial cells, as well as the presence of inflammatory 
cells (polynucleated or mononucleated cells), the increase in mesangial matrix and the 
accumulation of mesangial deposits (Moreau, 1989; Pașca, 2006). 
Proliferative glomerulonephritis may evolve either globally, affecting the whole 
glomerulus, or segmental, thus affecting some glomerular lobules. 
In the case of pure mesangio-proliferative glomerulonephritis, the mesangial and matriceal 
changes are exclusively confined to the axial region of the glomerulus, without modifying the 
caliber of the glomerular capillaries (Moreau, 1989). 
In segmental glomerulonephritis, hyperplasia located inside the structure of the glomerulus 
(glomerular polynucleosis) can produce a marked reduction in the caliber of glomerular capillaries 
due to external compression, down to complete stenosis, reduction of glomerular perfusion and 
sclerosis (Jergens, 1987; Perchereau, 1996). 
In electron microscopy, the fusion of the podocyte pedicels can be observed. Extra- 
membranary deposits are exceptionally observed in electron microscopy, but by means of 
immunohistochemistry, regular, homogeneous or granular deposits may be revealed sub- 
endothelially along the glomerular basal membrane containing IgG and IgM, without the C3 
fraction of the complement (Trautwein, 2000). 
Most cell proliferations are mediated by complement and platelet-derived factors. It has 





in PDGF (platelet derived growth factor) expression secreted by endothelial cells and PDGF 
receptor proteins, demonstrating that cell proliferation is based on autocrine mechanisms. 
These proliferative phenomena result in segmental and even general glomerular sclerosis, 
glomerular capillary collapse and adhesions between the vascular bundle and the Bowman capsule 
(Jones, 1986). 
The quantitative and qualitative balance of these lesions is indispensable in the histological 
prognosis. 
Occurrence of segmental or global proliferative glomerulonephritis was observed in 
infections with Leishmania sp. in dogs, mink plasmocytosis, infections with Streptococcus 
zooepidermicus in horses and chickens, etc. (McGavin, 2007). 
 
3. Membrane-proliferative glomerulonephritis (mesangio-capillary) 
Membrane-proliferative glomerulonephritis (MPGN), also called mesangio-capillary 
glomerulonephritis, is a morphoclinic entity that is characterized by proliferation of the mesangial 
cells and at the same time by the thickening of the glomerular basal membrane, thus meeting both 
aspects of membranous and mesangio-proliferative glomerulonephritis (Nakatsuji, 1998; Nevins, 
1985). 
These morphological aspects are considered to be intermediate lesions that end in 
generalized  chronic  glomerulonephritis,  leading  to  chronic  renal  failure  (Jergens,  1987). 
The structural changes within this type of lesion explain why the animals, respectively, show 
hematuria and nephritis concomitant with proteinuria and nephrotic syndrome. 
Membrane-proliferative glomerulonephritis may be associated with systemic features or 
well-defined pathologies (secondary GN) or, as in most cases, can be idiopathic (primary). 
Membrane-proliferative glomerulonephritis, as an autosomal dominant recessive disease, 
has been described in 20 Berneese Sheepdogs, with ages between 2 and 5 years, who had renal 
failure and severe proteinuria syndrome. It seems that the infection with Borrelia burgdorferi 
represents a triggering factor of the pathological process (Bernard, 1991; Gough, 2004). 
Based on the clinical and pathological aspects in both humans and animals, there are 3 
types of membrane-proliferative glomerulonephritis: type I, II and III, the last being very little 
known and controversial (Cotran, 1999; Roitt, 1992). 
a. Type I GNMP 
Type I membrane-proliferative glomerulonephritis are characterized histologically by an 
increased lobulation of the glomeruli caused by the proliferation of the mesangial cells and of the 
mesangial matrix. 
The process of epithelial and membrane proliferation may be extended to the whole 
glomerule, from the vascular pole to the urinary one, or localized to several capillary loops 
(glomerular lobules). 
In the first situation, the vascular bundle is retracted, more or less shrunken, partially 
thrombosed or with sclerosis (Moreau, 1989). 
In the second situation, the affected glomerular loops appear compact, the rest of the 
capillaries being permeable. 
On the whole, this category of glomerulonephritis is represented by severe lesions that do 
not allow healing without sequelae. The walls of the glomerular capillaries appear thickened as a 
result of subendothelial deposits consisting of immune complexes containing immunoglobulins 





Highlighting within the structure of the deposited immune complexes of C1q and C4 
fractions indicates that complement activation following the classical pathway plays an important 
role in the pathogenesis of type I GNMP. 
Another characteristic aspect of this type of glomerulonephritis is the so-called "mesangial 
interposition", which consists of the interposition of the cells and the mesangial matrix between 
the endothelium and the glomerular basal membrane. This phenomena confers a double contour to 
the glomerular basal membrane or the appearance of "tram rails", easily observable in silver 
impregnation and PAS staining methods. 
In dogs, type I membrane-proliferative glomerulonephritis predominantly develops as an 
idiopathic disease (Trautwein, 2000) However, some data suggest that it is sometimes possible to 
associate this type of lesion with systemic, bacterial (leishmaniasis and boreliosis in dogs) and viral 
infections (feline infectious peritonitis, cat leukosis, equine infectious anemia, African swine fever) 
or neoplasia. (Brostoff, 1991; Dambach, 1997; Oprean, 2000; Perianu, 1997). 
b. GNMP Type II (Dense Deposit Disease) 
The histological features are represented by the marked thickening of the PAS-positive 
basal glomerular membrane. The mesangium may be loose due to mesangial cell or matrix 
proliferation. 
The definitive diagnosis surges following the electron-microscopy highlighting of the 
deposits constituted by a dense, osmophilic material, in the thickness of the lamina densa of the 
basal glomerular membrane and the mesangium. 
The same characteristic of "mesangial interpositioning" is also found in the second type of 
membrane-proliferative glomerulonephritis (Cotran, 1999). Also, through immunohistochemistry, 
it has been observed that they are mainly constituted from the C3 fraction of the complement and 
properdine. 
In the pathology of glomerulonephritis in humans, the participation of IgG auto-antibodies 
against C3-convertase, called C3-critical factors (C3NeF), has been noted. The basal membrane 
stabilizes C3-convertase, the C3bBb enzyme of the alternative complement activation pathway and 
continues to deactivate C3 cleavage in C3b and C3a. 
Continuous activation of the complement gradually leads to the consumption of this 
element (hypocomplementemia). The level of the C3 fraction will be very low, but the C1q and C4 
fractions will remain within normal limits. 
c. Type III GNMP consists in the presence of immune deposits on both sides of the basal 
membrane at the same time (sub-endothelial and sub-epithelial). The lesion appears to be a type I 
variant (Cheville, 1994). 
Ig A Nephropathy (Berger's Disease) 
IgA nephropathy is the most common form of glomerulonephritis in humans, a common 
cause of asymptomatic hematuria. It can be observed in dogs and experimentally in mice (Bernard, 
1991) 
From a morphological point of view it is characterized by mesangial deposits of IgA, 
proliferation of the mesangial cells and expansion of the mesangial matrix (Brostoff, 1991). 
According to the histological criterion, this glomerular lesion falls into the category of 
membrane-proliferative glomerulonephritis. 
The research of the collective Bené (1984) established that the disease appears following 
the synthesis at abnormal levels of IgA or the synthesis of abnormally assembled IgA. In the first 
case, the abnormal IgA synthesis is due to the prolonged exposure of the mucous membranes to an 





surmounts the cleansing ability of the macrophageal-monocytic system, IgA which is then 
deposited in the glomerular level, in the glomerular mesangium (Day, 1988). 
The amount of complex circulating Ig A is directly proportional to the severity of the 
infection in the case of abnormal synthesis. In the second situation, the immune deposits that are 
found in the mesangium are composed of IgA1-glycosylated with an abnormal structure. Due to 
these abnormal structures of IgA1, the asialoglycan-proteins (macrophage receptors) cannot bind 
the macrophages of the macrophageal-monocytic system to initiate phagocytosis, favoring 
mesangial precipitation (Brostoff, 1991). 
Glomerular lesions due to the deposits of immune complexes containing IgA have been 
observed frequently in patients with hepatic cirrhosis. Studies on mice with induced cirrhosis by 
carbon tetrachloride intoxication have revealed the presence of circulating IgA with abnormal 
structure but also located on the glomerular basal membranes. 
he presence of C3 fraction in the structure of the mesangial deposits and that of the final 
components of the complement, except for the C1 and C4 fractions, suggests that activation of the 
complement following the alternative pathway mediated by IgA plays an important role in the 
pathogenesis of these types of mesangial-proliferative glomerulonephritis (Bovee, 1984; Braun, 
1995). 
The diagnosis of IgA nephropathy is based on the immunofluorescence highlighting of 
IgA deposits present in the glomerular mesangium (McCluskey, 1983). The highest prevalence of 
IgA glomerular deposits was observed in dogs with enteritis and hepatitis (Osborne, 1973). In the 
examined patients, co-deposits of IgM and IgG (Osborne, 1973) were also highlighted. 
 
4. Anti-basal membrane glomerulonephritis 
The name of this category of glomerulonephritis is reserved for the glomerular lesions 
produced by intrinsic anti-antigen antibodies of the basal membrane, which through interaction 
lead to the accumulation of membrane immune deposits. 
The experimental prototype is called Masugi nephritis or toxic nephritis and was obtained 
in mice by injecting them with anti-kidney antibodies, prepared on rabbits by immunization with 
mouse kidney tissue. 
Glomerulonephritis produced by anti-basal membrane antibodies is an autoimmune 
disease with severe and rapid evolution consisting of the formation of anti-basal membrane 
antibodies and their storage in renal tissue or other extrarenal tissues, more specifically in the 
glomerulus and sometimes, but not always, in the walls of the pulmonary alveoli. The origin of 
these antibodies is still unknown. 
This disease was experimentally reproduced in sheeps and dogs and used to elucidate the 
evolution of glomerular lesions with immune etiology (Bruijn, 1989). In this regard, circulating 
antibodies, produced by experimental immunization with heterologous antigenic basal membrane 
antigens, react with their endogenous antigens. 
The diagnosis of this glomerulonephritis consists in highlighting the linear deposits located 
on the external face of the glomerular capillaries, in the sub-epithelial space, consisting of anti- 






5. Sclero-hyaline glomerulonephritis (chronic) 
Sclero-hyaline glomerulonephritis are the most severe forms of glomerular lesions, 
represented by the advanced evolution of the lesions with degenerative effect on the structural and 
functional integrity of the glomerulus. 
All degenerative glomerular lesions linked to membranary deposists, represented by 
immune complexes or by other pathological constituents or by proliferation of reactive cells, 
slowly disappear, being replaced by an irreversible process of fibrosis (collagenization), with the 
increase in mesangial matrix and the disappearance of glomerular capillaries. The glomeruli 
become hypocellular and non-functional (Morel-Maroger, 1984; M.V.M. The Merck Veterinary 
Manual, 1998). 
Macroscopically, in the kidneys, glomerulosclerosis is manifested by a reduction in 
volume and a wrinkled aspect of the surface. On the sectioned surface, the cortex is atrophied, with 
a granular and yellowish appearance, due to the lipid accumulation (Fontaine, 1989). 
The histological aspect is conditioned by the evolutionary stage of the disease. In the early 
stages, we may see lesions of mesangio- or membrane-proliferative glomerulonephritis. 
Progressive hyalinization of glomeruli can be frequently observed by transforming them into an 
eosinifilic acellular block. The hyaline is the result of the absobtion of accumulated plasmatic 
proteins, the increase in mesangial matrix and collagenization (Cotran, 1999). 
The process can be generalized (involving all glomeruli) or focused. In addition, 
glomerulosclerosis can affect the entire glomerular structure (global) or only portions of the 
glomerular (segmental), presenting a nodular or segmental aspect at the level of the affected 
glomeruli. Over time, fibrous scars are formed in which vague remnants of the structure of the 
vascular bundle can be distinguished. 
The process of glomerular sclerosis severely affects the functionality of the nephron. Due 
to the particularities of the renal blood circulation, the disruption of the bloodstream in the 
glomerulus subsequently affects all structures irrigated from the efferent arteriole. Thus, the 
uriniferous tubes are subjected to hypoxia with the decreasing and then disruption of blood flow to 
the glomerulus. The result of hypoxia is death by apoptosis of the tubular epithelial cells. In 
addition, chronic proteinuria that accompanies glomerulosclerosis stimulates tubular nephrocyte 
apoptosis (Duffy, 1983; Euzeby, 1989). 
Many factors contribute to the acceleration of glomerulosclerosis. High levels of protein 
in food, increased blood pressure in functional glomeruli as a result of hypertensive diseases, 
cytokines and platelet growth factors ultimately lead to the acceleration and expansion of the 
process of sclerosis. These factors favor the alteration of the glomerular functional components, 
producing hyperfiltration and lesions of the capillary endothelium, activation of the mesangial cells 
and an increase of the mesangial matrix synthesis, degeneration of the visceral epithelium and 
finally the appearance of glomerular inter-epithelial synechiae (visceral parietal epithelium). 
(McGavin, 2007) 
Glomerulosclerosis is not only the final phase of glomerulonephritis, but is also the 
termination form of all chronic kidney damage that results in the structural and functional alteration 
of the nephrons (Fontaine-Verdier, 2003). 
Medium-intensity glomerulosclerosis have been observed in old dogs without however 
being able to determine the cause of the injury and occasionally in dogs with diabetes and 
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